Loading clinical trials...

Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection | Clinical Trials | Clareo Health

COMPLETEDNCT02326636

Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection

The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refrac...

Lead sponsor: University of California, Irvine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT06237452 · Clostridium Difficile, Clostridium Difficile Infections, and more

RECRUITING

Fecal Microbiota Transplant National Registry

NCT03325855 · Fecal Microbiota Transplantation, Clostridium Difficile Infection, and more

RECRUITINGPhase 2/3

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

NCT07221370 · Clostridium Difficile Infection, Vancomycin Resistant Enterococci Infection

RECRUITINGNA

Fecal Microbiota Transplantation for C Diff Infection

NCT01905709 · Clostridium Difficile Infection

RECRUITINGNA

Safety and Efficacy of Fecal Microbiota Transplantation

NCT04014413 · Crohn Disease, Ulcerative Colitis, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 21, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment37

Start dateApr 2014

Last updatedAug 21, 2023

Condition

Clostridium Difficile Infection

Locations shown

University of California, Irvine Medical Center

Orange, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 21, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions